The results indicated that ETHE1 expression could serve as an independent and meaningful prognostic factor for patients with CRC, suggesting that lower expression of ETHE1 may promote CRC malignant progression (Fig. 1K). Here, ETHE1 is linked to colorectal carcinoma.